Beacon Capital Management LLC (Tennessee)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-542
Closed -$60.1K 471
2025
Q2
$60.1K Buy
542
+23
+4% +$2.45K 0.01% 311
2025
Q1
$58.1K Sell
519
-500
-49% -$51.6K 0.01% 290
2024
Q4
$94.2K Buy
1,019
+103
+11% +$9.27K 0.01% 206
2024
Q3
$76.8K Sell
916
-22
-2% -$1.68K 0.01% 242
2024
Q2
$64.4K Sell
938
-58
-6% -$3.87K 0.01% 247
2024
Q1
$73K Buy
996
+373
+60% +$28.7K 0.02% 221
2023
Q4
$46.7K Sell
623
-28
-4% -$2.18K 0.01% 232
2023
Q3
$50.2K Hold
651
0.01% 248
2023
Q2
$50.2K Buy
651
+128
+24% +$10.2K 0.01% 248
2023
Q1
$43.4K Hold
523
0.01% 244
2022
Q4
$44.9K Hold
523
0.02% 237
2022
Q3
$32K Sell
523
-160
-23% -$10.1K 0.01% 274
2022
Q2
$40K Hold
683
0.01% 275
2022
Q1
$40K Buy
+683
New +$43.7K 0.01% 275

Other funds holding GILD

Beacon Capital Management LLC (Tennessee)'s GILD Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 542 shares — an estimated $60.1K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in GILD in Q1 2022 and held it in 14 quarters. The position peaked at $94.2K in Q4 2024. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Beacon Capital Management LLC (Tennessee) reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 542 Gilead Sciences shares in Q3 2025, an estimated $60.1K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Gilead Sciences in Q1 2022 and held it in 14 quarters.
  • Beacon Capital Management LLC (Tennessee)'s Gilead Sciences position peaked at $94.2K in Q4 2024.
  • 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.